NAT Stock Overview
Engages in the research, development, manufacturing, and marketing of omega 3 products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Iffe Futura, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.65 |
| 52 Week High | €0.84 |
| 52 Week Low | €0.59 |
| Beta | -0.36 |
| 11 Month Change | 0.78% |
| 3 Month Change | -7.19% |
| 1 Year Change | -14.00% |
| 33 Year Change | 1.57% |
| 5 Year Change | -66.75% |
| Change since IPO | -57.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NAT | ES Food | ES Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | -0.03% |
| 1Y | -14.0% | -7.6% | 12.6% |
Return vs Industry: NAT underperformed the Spanish Food industry which returned -6.7% over the past year.
Return vs Market: NAT underperformed the Spanish Market which returned 14.2% over the past year.
Price Volatility
| NAT volatility | |
|---|---|
| NAT Average Weekly Movement | 6.0% |
| Food Industry Average Movement | 3.0% |
| Market Average Movement | 3.0% |
| 10% most volatile stocks in ES Market | 6.0% |
| 10% least volatile stocks in ES Market | 0.7% |
Stable Share Price: NAT has not had significant price volatility in the past 3 months.
Volatility Over Time: NAT's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Spanish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 17 | David Carro Meana | www.iffefutura.es |
Iffe Futura, S.A. engages in the research, development, manufacturing, and marketing of omega 3 products. The company’s products are used in food, pharmaceutical, animal, nutritional supplements, cosmetics, and other industries. Iffe Futura, S.A. was incorporated in 2011 and is based in Madrid, Spain.
Iffe Futura, S.A. Fundamentals Summary
| NAT fundamental statistics | |
|---|---|
| Market cap | €280.45m |
| Earnings (TTM) | -€621.61k |
| Revenue (TTM) | €1.11m |
252.8x
P/S Ratio-451.2x
P/E RatioIs NAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NAT income statement (TTM) | |
|---|---|
| Revenue | €1.11m |
| Cost of Revenue | €358.73k |
| Gross Profit | €750.62k |
| Other Expenses | €1.37m |
| Earnings | -€621.61k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0014 |
| Gross Margin | 67.66% |
| Net Profit Margin | -56.03% |
| Debt/Equity Ratio | 10.2% |
How did NAT perform over the long term?
See historical performance and comparison